Mutation in the pfcrt and pfmdr-1, genes have been implicated both to be putative CQ resistance markers. Blood samples from 130 volunteers were obtained and genotyped by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) for pfmdr1 and pfcrt genes. A total of 40(30.8%) questionnaires were administered to the adults and 90(69.2%) were administered to the school children. 14(10.8%) had microscopically detectable parasites on day zero with a mean parasites counts of 40,231 parasites/µL. CQ was administered to all infected, higher parasite density was observed in the poorer population. PCR-RFLP analysis on 14 parasite positive samples for pfcrt and pfmdr genotypes showed polymorphism around pfmdr1 N86Y. The para...
Malaria remains a key component of the infectious disease burden across much of the globe with a par...
This study aimed at evaluating the distribution of malaria, Plasmodium falciparum resistant chloroqu...
In the Democratic Republic of the Congo (DRC), artesunate-amodiaquine is first-line therapy for falc...
Background: Antimalarial drug resistance has been a major contributor to the failure of the battle a...
BACKGROUND: In Nigeria, despite the change in National malaria drug policy to artemisinin combinatio...
During an epidemic of Plasmodium falciparum malaria in Chogoria, Kenya, P. falciparum DNA was collec...
This research evaluated the distribution of malaria, Plasmodium falciparum chloroquine resistance tr...
This study was undertaken to validate the relevance of Chloroquine (CQ) resistance markers pfert76 a...
Introduction. Despite the efforts of the malaria control programme, malaria morbidity is still a com...
The successful use of chloroquine(CQ) through the decades finally resulted in CQ resistant(CQR) Plas...
Background: Malaria eradication globally is yet to be achieved and transmission is sustained in many...
BACKGROUND: Parasite resistance to the anti-malarial drug chloroquine is common in eastern Sudan. Dy...
The development in Plasmodium falciparum of the resistance to chloroquine (CQ) constitutes a public ...
Abstract Background Malaria still poses one of the major threats to human health. Development of eff...
Background & objectives: High mortality and morbidity in sickle-cell disease has been associated...
Malaria remains a key component of the infectious disease burden across much of the globe with a par...
This study aimed at evaluating the distribution of malaria, Plasmodium falciparum resistant chloroqu...
In the Democratic Republic of the Congo (DRC), artesunate-amodiaquine is first-line therapy for falc...
Background: Antimalarial drug resistance has been a major contributor to the failure of the battle a...
BACKGROUND: In Nigeria, despite the change in National malaria drug policy to artemisinin combinatio...
During an epidemic of Plasmodium falciparum malaria in Chogoria, Kenya, P. falciparum DNA was collec...
This research evaluated the distribution of malaria, Plasmodium falciparum chloroquine resistance tr...
This study was undertaken to validate the relevance of Chloroquine (CQ) resistance markers pfert76 a...
Introduction. Despite the efforts of the malaria control programme, malaria morbidity is still a com...
The successful use of chloroquine(CQ) through the decades finally resulted in CQ resistant(CQR) Plas...
Background: Malaria eradication globally is yet to be achieved and transmission is sustained in many...
BACKGROUND: Parasite resistance to the anti-malarial drug chloroquine is common in eastern Sudan. Dy...
The development in Plasmodium falciparum of the resistance to chloroquine (CQ) constitutes a public ...
Abstract Background Malaria still poses one of the major threats to human health. Development of eff...
Background & objectives: High mortality and morbidity in sickle-cell disease has been associated...
Malaria remains a key component of the infectious disease burden across much of the globe with a par...
This study aimed at evaluating the distribution of malaria, Plasmodium falciparum resistant chloroqu...
In the Democratic Republic of the Congo (DRC), artesunate-amodiaquine is first-line therapy for falc...